ENDONOVO THERAPEUTICS, INC. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENDONOVO THERAPEUTICS, INC. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,603,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 113 | 21,598,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,593,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,588,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,583,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,578,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,573,123 | 21.6 M to 21.6 M (+0.05 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,563,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 120 | 21,558,123 | 21.6 M to 21.6 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 230 | 21,553,123 | 21.5 M to 21.6 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 46 | 21,543,123 | 21.5 M to 21.5 M (+0.01 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,541,123 | 21.5 M to 21.5 M (0.00 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 4,000 | 90 | 21,540,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,536,123 | 21.5 M to 21.5 M (0.00 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,535,123 | 21.5 M to 21.5 M (0.00 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 227 | 21,534,123 | 21.5 M to 21.5 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 342 | 21,524,123 | 21.5 M to 21.5 M (+0.07 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 226 | 21,509,123 | 21.5 M to 21.5 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 335 | 21,499,123 | 21.5 M to 21.5 M (+0.07 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,484,123 | 21.5 M to 21.5 M (0.00 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,483,123 | 21.5 M to 21.5 M (0.00 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,482,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,477,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,472,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,467,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,462,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,457,123 | 21.5 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,452,123 | 21.4 M to 21.5 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 233 | 21,447,123 | 21.4 M to 21.4 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 116 | 21,437,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,432,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 117 | 21,427,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,422,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,417,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,412,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,407,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 109 | 21,402,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 219 | 21,397,123 | 21.4 M to 21.4 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 219 | 21,387,123 | 21.4 M to 21.4 M (+0.05 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 109 | 21,377,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,372,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 21 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 110 | 21,367,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 112 | 21,362,123 | 21.4 M to 21.4 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 56 | 21,357,123 | 21.4 M to 21.4 M (+0.01 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,354,623 | 21.3 M to 21.4 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 335 | 21,344,623 | 21.3 M to 21.3 M (+0.07 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,329,623 | 21.3 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 223 | 21,319,623 | 21.3 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 15,000 | 333 | 21,309,623 | 21.3 M to 21.3 M (+0.07 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 222 | 21,294,623 | 21.3 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 221 | 21,284,623 | 21.3 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 221 | 21,274,623 | 21.3 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,264,623 | 21.3 M to 21.3 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,259,623 | 21.3 M to 21.3 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,254,623 | 21.2 M to 21.3 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,244,623 | 21.2 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,234,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,229,623 | 21.2 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,219,623 | 21.2 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,209,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 226 | 21,204,623 | 21.2 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,194,193 | 21.2 M to 21.2 M (0.00 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 222 | 21,193,623 | 21.2 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 23 | 21,183,623 | 21.2 M to 21.2 M (0.00 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,182,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,177,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,172,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 114 | 21,167,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 113 | 21,162,623 | 21.2 M to 21.2 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 229 | 21,157,623 | 21.1 M to 21.2 M (+0.05 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 115 | 21,147,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 58 | 21,142,623 | 21.1 M to 21.1 M (+0.01 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,500 | 58 | 21,140,123 | 21.1 M to 21.1 M (+0.01 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 111 | 21,137,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 22 | 21,132,623 | 21.1 M to 21.1 M (0.00 %) |
| Feb 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 52 | 26,703,897 | 26.7 M to 26.7 M (+0.01 %) |
| Feb 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 52 | 26,701,897 | 26.7 M to 26.7 M (+0.01 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 1,000 | 26 | 21,093,623 | 21.1 M to 21.1 M (0.00 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,092,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,087,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 129 | 21,087,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,082,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,077,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 127 | 21,072,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 127 | 21,067,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 130 | 21,062,623 | 21.1 M to 21.1 M (+0.02 %) |
| Feb 05 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.03 | 5,000 | 131 | 21,057,623 | 21.1 M to 21.1 M (+0.02 %) |